Telix Pharmaceuticals (TLX) Assets Average (2024)
Telix Pharmaceuticals (TLX) posted Assets Average of $628.0 million for Q4 2024.
Telix Pharmaceuticals (TLX) has 1 years of Assets Average data on file, last reported at $628.0 million in Q4 2024.
- In Q4 2024, Assets Average changed N/A year-over-year to $628.0 million; the TTM figure through Dec 2024 stood at $628.0 million (changed N/A YoY), while the FY2025 annual figure was $1.1 billion, up 71.64% from the prior year.
- Assets Average steadied at $628.0 million in Q4 2024.
- Across five years, Assets Average topped out at $628.0 million in Q4 2024 and bottomed at $628.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Telix Pharmaceuticals | 4.52 Bn | 4.38 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 627.98 Mn |